BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17910636)

  • 21. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.
    Moreno DA; Scrideli CA; Cortez MA; de Paula Queiroz R; Valera ET; da Silva Silveira V; Yunes JA; Brandalise SR; Tone LG
    Br J Haematol; 2010 Sep; 150(6):665-73. PubMed ID: 20636436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence and features of pre-B-cell acute lymphoblastic leukemia in Mexico: description of 9 patients].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Sangre (Barc); 1991 Feb; 36(1):1-5. PubMed ID: 1906639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
    Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y
    Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
    Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
    Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
    Wehrli LA; Braun J; Buetti LN; Hagleitner N; Hengartner H; Kühne T; Lüer S; Ozsahin H; Popovic MB; Niggli FK; Betts DR; Bourquin JP
    Cancer Genet Cytogenet; 2009 Feb; 189(1):29-36. PubMed ID: 19167609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.
    Terwijn M; Feller N; van Rhenen A; Kelder A; Westra G; Zweegman S; Ossenkoppele G; Schuurhuis GJ
    Eur J Cancer; 2009 Jun; 45(9):1692-9. PubMed ID: 19321337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
    Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
    Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.
    Uyttebroeck A; Suciu S; Laureys G; Robert A; Pacquement H; Ferster A; Marguerite G; Mazingue F; Renard M; Lutz P; Rialland X; Mechinaud F; Cavé H; Baila L; Bertrand Y;
    Eur J Cancer; 2008 Apr; 44(6):840-6. PubMed ID: 18342502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases].
    Jmili NB; Souguir S; Yacoub S; Khelif A; Kortas M
    Ann Biol Clin (Paris); 2009; 67(5):543-51. PubMed ID: 19789126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.